WFH Humanitarian Aid Program puts Armenia on the path to sustainable care

Armenia’s hemophilia community has undergone a profound transformation over the past two decades, shaped by the resilience of families and the long-standing partnership between the Armenian Association of Haemophilia and Thrombophilia, the medical community, and the World Federation of Hemophilia (WFH). During a recent visit to Armenia, a WFH Humanitarian Aid Program delegation saw how long-term commitment has brought real change to the country, which is now well on its way to being able to offer care to its inherited bleeding disorders community sustainably.

Also available in: Français Español

“I am a Vice President of the Armenian Association of Haemophilia and Thrombophilia, and at the same time, I’m a parent of a person suffering from hemophilia,” said Natalya Barinyan, recalling the fear and uncertainty she faced in 1998 when her son was diagnosed. “There were no medicines… They usually [only] used ice and very primitive drugs to treat [him].” The hardships faced by so many at that time were due to many factors. According to Karine Kocharyan, WFH Regional Manager, Europe and Central Asia, Armenia’s inherited Soviet-era healthcare system, compounded by conflict and economic hardship, made access to medical care difficult in general. For people with hemophilia, things were especially difficult. In 1997, when the Armenian Hemophilia Association was founded, here were little more than cryoprecipitate and fresh frozen plasma available in hospitals.

Things improved for the community when, a few years after the Armenian Hemophilia Association became a WFH national member organization (NMO) in 1998, WFH Humanitarian Aid Program donations started arriving.

We see a huge difference between the first time we were here in 2016 and today… We hope that in 2030, hemophilia care will be nation-wide in Armenia.

—Assad H. Haffar, MD, WFH Director of Humanitarian Aid and Medical Training

On a recent visit to the country, corporate representative Scott Williams saw the change in the country firsthand. “Patients have the opportunity today to have access [to care] that was not possible ten years ago… I was so struck by the strength of advocacy.” He praised families that were, “going above and beyond for their children.”

Barinyan explained that the improvement in the level of care since the mid-nineties has been life changing, with the new generation enjoying the kind of support their parents wouldn’t have dreamed of. “Our patients—lucky people—they have access to perfectly trained doctors… there is no comparison,” she says.

Assad H. Haffar, MD, WFH Director of Humanitarian Aid and Medical Training, explained that Armenia has made remarkable progress in hemophilia care, notably in the capital, but that work remains to be done in regional areas. He expressed hope that by 2030 care will be accessible nationwide—a goal he believes is achievable with continued partnership and commitment.

This story is the final part in a three-part series. To read the first article, “Long-term collaboration transforms hemophilia care in Armenia”, please click here. To read the second article, “Improved care brings hope to Armenian families living with hemophilia” please click here.

WFH efforts in Armenia have included multiple initiatives besides the WFH Humanitarian Aid Program, such as the WFH International External Quality Assessment Scheme (IEQAS), which helps hemophilia treatment centres (HTCs) monitor and strengthen laboratory performance; and a Hemophilia Organization Twinning (HOT) partnership that connects developing patient organizations with more established ones to exchange expertise and build capacity.

The WFH Humanitarian Aid Program has donated nearly 19 million IUs of factor and over 310,000 mg of non-factor replacement therapy to Armenia since 2015. Over 3 million IUs of factor, and over 50,000 mg of non-factor replacement therapy were donated in 2025 alone. To find out more about the WFH Humanitarian Aid Program please click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda, our Contributor. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.